Finding the best treatment for a migraine patient is often a problem in clinical practice since the condition is very common and disabling. The drugs most commonly used for migraine prophylaxis are beta-blockers, calcium antagonist and serotonin modulators. Recently, several double-blind trials have affirmed the efficacy of valproic acid in migraine prophylaxis: the valproic acid is especially useful when migraine occurs in patients with epilepsy, anxiety disorders, or bipolar disorder.
|Translated title of the contribution||The role of valproic acid in migraine prophylaxis|
|Number of pages||3|
|Journal||Bollettino - Lega Italiana contro l'Epilessia|
|Issue number||95-96 SUPPL. 1|
|Publication status||Published - 1996|
ASJC Scopus subject areas
- Clinical Neurology